High levels of APRIL (Fig. 1 B) and BAFF (Fig. 1 C) were detected in MM patients, also consistent with previous reports that both ligands serve as biomarkers of various B cell malignancies (Bolkun et al., 2014; Fragioudaki et al., 2012). This evidence concerns the gene TNFSF13B and Miyoshi myopathy.